RICI HEALTH (01526) released its interim results, reporting a profit attributable to shareholders of 45.547 million yuan, a year-on-year decrease of 18.58%.
Ruici Medical (01526) announced its interim results for the six months ended June 30, 2026. The group reported revenue of RMB 1.139 billion, a year-on-year decrease of 0.55%; the profit attributable to shareholders was RMB 45.547 million, a year-on-year decrease of 18.58%; earnings per share were RMB 0.03.
RICI HEALTH (01526) released its interim results for the six months ending June 30, 2026, reporting revenue of RMB 1.139 billion, a year-on-year decrease of 0.55%; profit attributable to equity holders of the company was RMB 45.547 million, a year-on-year decrease of 18.58%; earnings per share were RMB 0.03.
Related Articles
TRANSCENTA-B (06628) released its interim results, reporting a shareholder loss of 67.347 million yuan, a year-on-year reduction of 38.66%.
FRONTIER SER(00500) announced its interim results, reporting a loss attributable to shareholders of HKD 20.09 million, an increase of 142.8% compared to the same period last year.
ZHAOKE OPHTH-B (06622) announced its interim results with a net loss of approximately 123 million yuan, an increase of 5.12% year-on-year.
TRANSCENTA-B (06628) released its interim results, reporting a shareholder loss of 67.347 million yuan, a year-on-year reduction of 38.66%.
FRONTIER SER(00500) announced its interim results, reporting a loss attributable to shareholders of HKD 20.09 million, an increase of 142.8% compared to the same period last year.
ZHAOKE OPHTH-B (06622) announced its interim results with a net loss of approximately 123 million yuan, an increase of 5.12% year-on-year.
RECOMMEND
